PERPHENAN 4 MG

Nchi: Israeli

Lugha: Kiingereza

Chanzo: Ministry of Health

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
20-07-2021
Tabia za bidhaa Tabia za bidhaa (SPC)
12-04-2021

Viambatanisho vya kazi:

PERPHENAZINE

Inapatikana kutoka:

TARO PHARMACEUTICAL INDUSTRIES LTD

ATC kanuni:

N05AB03

Dawa fomu:

FILM COATED TABLETS

Tungo:

PERPHENAZINE 4 MG

Njia ya uendeshaji:

PER OS

Dawa ya aina:

Required

Viwandani na:

TARO PHARMACEUTICAL INDUSTRIES LTD

Kundi la matibabu:

PERPHENAZINE

Eneo la matibabu:

PERPHENAZINE

Matibabu dalili:

Tranquilizer,antiemetic.

Idhini ya tarehe:

2021-03-31

Taarifa za kipeperushi

                                [לוגו מדינת ישראל] [http://www.gov.il/]
[http://www.gov.il/] [לוגו משרד הבריאות] [לוגו משרד
הבריאות] [*5400]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
הציבור הרחב עסקים ומוסדות עובדים
בבריאות חפש מידע
תפריט	*
[סגירה]
סגור	*
דף הבית [http://www.health.gov.il/]	*
אודות	*
אודות המשרד
[http://www.health.gov.il/About/Pages/about_us.aspx]	*
תוכנית עבודה
[http://www.health.gov.il/About/Pages/Agenda.aspx]	*
תקציב המשרד
[http://www.health.gov.il/About/Pages/budget.aspx]	*
תרשים מבנה ארגוני
[http://www.health.gov.il/About/Pages/OrganizationalStructureDiagram.aspx]	*
בעלי תפקידים
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx]	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx?tab=3]	*
אמנת שירות
[http://www.health.gov.il/About/sla/Pages/default.aspx]	*
אותות ופרסים
[http://www.health.gov.il/About/Awards/Pages/mifal.aspx]	*
פרוייקטים תשתיתיים
[http://www.health.gov.il/About/projects/shared_medical_info/Pages/default.aspx]	*
דרושים
[http://www.health.gov.il/About/Careers/Pages/default.aspx]	*
מנכ"לי משרד הבריאות לדורותיהם
[http://www.health.gov.il/About/Pages/GeneralManegerHistory.aspx]	*
יחידות המשרד	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/UnitsOffice/LB/Pages/default.aspx]	*
וועדות ומועצות
[http://www.health.gov.il/Services/Committee/Pages/CommitteeList.aspx]	*
נושאים	*
בריאות הנפש
[http://www.health.gov.il/Subjects/mental_health/Pages/default.aspx]	*
בריאות הסביבה
[http://www.health.gov.il/Subjects/Environmental_Health/
                                
                                Soma hati kamili
                                
                            

Tabia za bidhaa

                                Page
1
of
10
Perphenan 4 and 8 mg –SPC-Clean-02.2021
PERPHENAN FILM COATED TABLETS
NAME OF THE MEDICINAL PRODUCT
Perphenan 4mg
Perphenan 8mg
QUALITATIVE AND QUANTITATIVE COMPOSITION
Perphenan 4mg - Each tablet contains 4mg Perphenazine
Perphenan 8mg - Each tablet contains 8mg Perphenazine
PHARMACEUTICAL FORM
Film coated tablet
Perphenan 4 mg - White, round, bi-convex, coated tablets.
Both sides plain.
Perphenan 8 mg - Gray, round, bi-convex, coated tablets. Both sides
plain.
THERAPEUTIC INDICATIONS
Tranquilizer, antiemetic
WARNING
INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED
PSYCHOSIS
ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS TREATED WITH
ANTIPSYCHOTIC DRUGS ARE AT
AN INCREASED RISK OF DEATH. ANALYSES OF SEVENTEEN PLACEBO-CONTROLLED
TRIALS (MODAL
DURATION OF 10 WEEKS), LARGELY IN PATIENTS TAKING ATYPICAL
ANTIPSYCHOTIC DRUGS, REVEALED A
RISK OF DEATH IN DRUG-TREATED PATIENTS OF BETWEEN 1.6 TO 1.7 TIMES THE
RISK OF DEATH IN
PLACEBO-TREATED PATIENTS. OVER THE COURSE OF A TYPICAL 10-WEEK
CONTROLLED TRIAL, THE RATE
OF DEATH IN DRUG TREATED PATIENTS WAS ABOUT 4.5%, COMPARED TO A RATE
OF ABOUT 2.6% IN
THE PLACEBO GROUP.
ALTHOUGH THE CAUSES OF DEATH WERE VARIED, MOST OF THE DEATHS APPEARED
TO BE EITHER
CARDIO VASCULAR (E.G., HEART FAILURE, SUDDEN DEATH) OR INFECTIOUS
(E.G., PNEUMONIA) IN
NATURE.
OBSERVATIONAL STUDIES SUGGEST THAT, SIMILAR TO ATYPICAL ANTIPSYCHOTIC
DRUGS, TREATMENT
WITH CONVENTIONAL ANTIPSYCHOTIC DRUGS MAY INCREASE MORTALITY. THE
EXTENT TO WHICH THE
FINDINGS OF INCREASED MORTALITY IN OBSERVATIONAL STUDIES MAY BE
ATTRIBUTED TO THE
ANTIPSYCHOTIC DRUG AS OPPOSED TO SOME CHARACTERISTIC(S) OF THE
PATIENTS IS NOT CLEAR.
PERPHENAZINE IS NOT APPROVED FOR THE TREATMENT OF PATIENTS WITH
DEMENTIA-RELATED
PSYCHOS IS (SEE WARNINGS).
DESCRIPTION
Perphenazine
(4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol), a
piperazinyl
phenothiazine, having the chemical formula, C
21
H
26
CIN
3
OS. It is available as oral tablets
containing 4 mg and 8 mg of perphenazine.
Page
2
of
10
Perphenan 
                                
                                Soma hati kamili
                                
                            

Nyaraka katika lugha zingine

Taarifa za kipeperushi Taarifa za kipeperushi Kiarabu 20-07-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kiebrania 20-07-2021

Tafuta arifu zinazohusiana na bidhaa hii

Tazama historia ya hati